Table 3B.
Fine-Gray models for the outcome of transplantation from the time of ESRD onset in the “very healthy” sub-cohort by race/ethnicity.
| HEALTHY COHORT | ||||||
|---|---|---|---|---|---|---|
| Overall (living or deceased) (N=239,248) |
Number of years after dialysis initiation | |||||
| Unadjusted | Year 0 | Year 1 | Year 2 | Year 3 | Year 4 | Year 5 |
| Non-Hispanic White (Ref) | Ref | Ref | Ref | Ref | Ref | Ref |
| Non-Hispanic Black | 0.22 (0.21-0.23) | 0.31 (0.30-0.33) | 0.45 (0.41-0.48) | 0.64 (0.57-0.70) | 0.90 (0.80-1.02) | 1.28 (1.12-1.47) |
| Hispanic | 0.33 (0.31-0.34) | 0.41 (0.39-0.44) | 0.52 (0.48-0.57) | 0.66 (0.59-0.74) | 0.84 (0.74-0.96) | 1.07 (0.92-1.24) |
| Adjusteda | Year 0 | Year 1 | Year 2 | Year 3 | Year 4 | Year 5 |
| Non-Hispanic White (Ref) | Ref | Ref | Ref | Ref | Ref | Ref |
| Non-Hispanic Black | 0.23 (0.22-0.24) | 0.32 (0.29-0.34) | 0.44 (0.40-0.49) | 0.62 (0.55-0.69) | 0.86 (0.75-0.98) | 1.20 (1.02-1.40) |
| Hispanic | 0.39 (0.37-0.41) | 0.48 (0.44-0.53) | 0.60 (0.54-0.67) | 0.75 (0.66-0.85) | 0.93 (0.80-1.09) | 1.16 (0.97-1.39) |
| Deceased donor transplantation | ||||||
| Unadjusted | Year 0 | Year 1 | Year 2 | Year 3 | Year 4 | Year 5 |
| Overall | ||||||
| Non-Hispanic White (Ref) | Ref | Ref | Ref | Ref | Ref | Ref |
| Non-Hispanic Black | 0.29 (0.28-0.32) | 0.39 (0.36-0.43) | 0.52 (0.46-0.59) | 0.69 (0.60-0.80) | 0.92 (0.78-1.10) | 1.22 (1.00-1.49) |
| Hispanic | 0.29 (0.26-0.31) | 0.37 (0.33-0.41) | 0.47 (0.41-0.55) | 0.61 (0.51-0.73) | 0.78 (0.63-0.97) | 1.00 (0.78-1.28) |
| Adjusteda | Year 0 | Year 1 | Year 2 | Year 3 | Year 4 | Year 5 |
| Overall | ||||||
| Non-Hispanic White (Ref) | Ref | Ref | Ref | Ref | Ref | Ref |
| Non-Hispanic Black | 0.32 (0.30-0.34) | 0.43 (0.39-0.47) | 0.57 (0.51-0.65) | 0.77 (0.66-0.89) | 1.03 (0.89-1.22) | 1.37 (1.12-1.68) |
| Hispanic | 0.38 (0.34-0.42) | 0.49 (0.43-0.55) | 0.63 (0.53-0.74) | 0.81 (0.67-0.98) | 1.04 (0.83-1.30) | 1.34 (1.03-1.74) |
| Living donor transplantation | ||||||
| Unadjusted | Year 0 | Year 1 | Year 2 | Year 3 | Year 4 | Year 5 |
| Overall | ||||||
| Non-Hispanic White (Ref) | Ref | Ref | Ref | Ref | Ref | Ref |
| Non-Hispanic Black | 0.18 (0.17-0.20) | 0.25 (0.22-0.28) | 0.34 (0.29-0.40) | 0.46 (0.37-0.58) | 0.63 (0.49-0.82) | 0.87 (0.64-1.18) |
| Hispanic | 0.33 (0.31-0.36) | 0.45 (0.40-0.51) | 0.62 (0.53-0.73) | 0.85 (0.69-1.04) | 1.16 (0.90-1.48) | 1.58 (1.18-2.11) |
| Adjusteda | Year 0 | Year 1 | Year 2 | Year 3 | Year 4 | Year 5 |
| Non-Hispanic White (Ref) | Ref | Ref | Ref | Ref | Ref | Ref |
| Non-Hispanic Black | 0.19 (0.18-0.21) | 0.26 (0.23-0.30) | 0.36 (0.30-0.42) | 0.48 (0.39-0.60) | 0.66 (0.51-0.86) | 0.90 (0.66-1.23) |
| Hispanic | 0.40 (0.37-0.44) | 0.55 (0.49-0.63) | 0.76 (0.65-0.90) | 1.05 (0.85-1.30) | 1.45 (1.12-1.87) | 2.00 (1.48-2.70) |
a
Adjusted for age at ESRD onset (whichever is first), sex, median income by neighborhood zip code, insurance status, and region of the US, BMI, CAD, cerebrovascular disease, heart failure, diabetes, hypertension, tobacco, alcohol, and drug dependence, ESRD network, and calendar year of initiation.